ORGANOPHOSPHATE RESPONSE PATHWAY (PW:0001516) Description
Organophosphorous compounds (OPCs) are used as pesticides in agriculture, particularly as insecticides, and occasionally in industrial settings. As nerve agents, they have been used in warfare in the past; OPCs have been used in modern chemical warfare and in terrorist attacks. In some countries, OPCs are used for self-poisoning. OPCs poisoning, whether accidental from occupational exposure or intentional, is a serious public health issue. The main mechanism of toxicity is the inhibition of acetylcholinesterase AChE resulting in uncensored acetylcholine (ACh) signaling. ACh is a neurotransmitter and neuromodulator that plays important roles in the central and peripheral nervous system and also in non-neuronal cells. It performs its manifold functions by activating the ionotropic nicotinic (nAChRs) and the metabotropic (mAChRs) receptors. [To see acetylcholine signaling via nicotinic receptors
click here , via muscarinic receptors,
click here and for an overall depiction of the acetylcholine system,
click here ]. The signal is terminated by the hydrolysis of ACh by Ache - a very fast acting enzyme accounting for ACh clearance in less than a millisecond (
click the see the structure of the apo human enzyme ;
or in combination with the anti-Alzheimer drug Donepezil . OPCs poisoning leads to neuronal excitotoxicity and damage and affects the cardiovascular, musculoskeletal, respiratory and gastrointestinal systems. A primary cause of death is respiratory failure due to muscle paralysis, bronchial and brain respiratory systems dysfunction; cardiovascular failure can also occur. In vivo and in vitro studies in rats show a range of developmental neurotoxic effects of OPCs. Structurally, OPCs are ester, thiol or amide derivatives of phosphoric acid, phosphonic acid or phosphinic acid and hundreds different compounds are available. The mechanism of Ache inactivation involves the formation of a covalent bond between the OPC's phosphoryl group and the hydroxyl group of a serine residue in the active site of Ache; the inactivation is largely irreversible. Some of the extensively used insecticides, such as parathion and chlorpyrifos are phosphorothionates. The oxidative desulfuration of P=S moiety is carried out by members of the cytochrome P450 family, CYP2B6 primarily. The resulting 'oxon' metabolites - paraoxon and chlorpyrifos oxon, respectively, are the potent Ache inhibitors. Some OPCs metabolism is carried out by paraoxonases - arylesterases that can hydrolyze OPCs. Pon1 is a primary esterase; the calcium-dependent enzyme catalyzes the hydrolysis of cyclic lactones such as homocysteine thiolactone. Pon1 has a broad substrate specificity which probably accounts for its activity towards OPCs and other xenobiotics (
click to access the PDB entry for the crystal structure ). The finding that the parathion derived paraoxon metabolite is a substrate for PON1, lead to its identification as a phosphotriesterase. Parathion, still in use in parts of the world, has been banned in the United States and other countries; its place taken by the related but less toxic methyl parathion. Several approaches are used to counteract OPCs poisoning (OPP), largely with relative efficacy. Oximes, also known as cholinesterase reactivators, are chemical compounds aiming at restoring (reactivating) the Ache by splitting the OPC-enzyme bond. Of the several commercially available, pralidoxime is the most commonly used. Their efficacy varies and many do not cross the blood-brain barrier thus limiting their effect on the central nervous system. Oxime administration must be fast as the phosphorylated Ache can undergo 'aging' - a time-dependent loss of one alkyl group bound to phosphorous which prohibits the reactivation reaction. Other approaches do not involve actual anti-OPCs but are used because their actions can alleviate some of the symptoms of PCs, poisoning. They include atropine - a competitive antagonist for the muscarinic receptors that reduces several of the symptoms and diazepam, one of a class of benzodiazepines with depressant functions, as an anticonvulsant. A standard therapy consists of combinations of oximes, atropine and diazepine. In addition to Ache, OPCs form adducts on several other proteins, the most notable example being albumin. The phosphorylated tyrosine - documented in humans and mice, is not subject to aging or substrate for oximes; this coupled to the high abundance and long half-life of the protein renders albumin as useful biomarker for OPC exposure despite a lower reaction rate, compared to Ache.
click to see the ontology report for annotations, GViewer and download .
...(less)
Pathway Diagram:
GO TO:
Genes in Pathway:
Symbol
Object Name
Evidence
Notes
Source
PubMed Reference(s)
RGD Reference(s)
Position
G
Ache
acetylcholinesterase
ISO
RGD
PMID:24508992
RGD:8551790
NCBI chr12:25,042,882...25,050,608
Ensembl chr12:19,407,360...19,413,651
G
Alb
albumin
ISO
RGD
PMID:23261756
RGD:8551793
NCBI chr14:17,891,564...17,907,043
Ensembl chr14:17,607,381...17,622,836
G
Cyp2b3
cytochrome P450, family 2, subfamily b, polypeptide 3
ISO
RGD
PMID:22155227
RGD:8551791
NCBI chr 1:90,780,468...90,859,852
Ensembl chr 1:81,652,787...81,732,143
G
Pon1
paraoxonase 1
ISO
RGD
PMID:19433263
RGD:8551792
NCBI chr 4:34,261,312...34,292,327
Ensembl chr 4:33,294,722...33,321,360
Pathway Gene Annotations
Disease Annotations Associated with Genes in the organophosphate response pathway
Ache acute stress disorder , Alzheimer's disease , amphetamine abuse , amyloidosis , anemia , autism spectrum disorder , bacterial meningitis , Binge Drinking , Breast Neoplasms , Cadmium Poisoning , cannabis dependence , Colorectal Neoplasms , drug dependence , Drug-Related Side Effects and Adverse Reactions , Endotoxemia , epilepsy , Experimental Diabetes Mellitus , Experimental Liver Cirrhosis , Growth Disorders , heroin dependence , Hirschsprung's disease , Huntington's disease , learning disability , leptospirosis , Memory Disorders , movement disease , multiple sclerosis , muscular dystrophy , myasthenia gravis , nervous system disease , obesity , Organophosphate Poisoning , Parkinson's disease , pleomorphic xanthoastrocytoma , Poisoning , Prenatal Injuries , Prostatic Neoplasms , renal cell carcinoma , Stroke , subacute delirium , Tremor , type 1 diabetes mellitus , urinary bladder cancer Alb Acute Coronary Syndrome , acute kidney failure , Acute Liver Failure , Acute Lung Injury , adult respiratory distress syndrome , Albuminuria , alcoholic hepatitis , allergic disease , Analbuminemia , angioedema , Animal Disease Models , anuria , aseptic meningitis , autoimmune thrombocytopenic purpura , azoospermia , biliary tract benign neoplasm , blood protein disease , brain disease , Brain Injuries , brain ischemia , Burns , Carcinoid Tumor , cardiovascular system disease , Chemical and Drug Induced Liver Injury , Chemically-Induced Disorders , cholangiocarcinoma , cholestasis , Chronic Allograft Nephropathy , Colorectal Neoplasms , congestive heart failure , COVID-19 , Delayed Hypersensitivity , depressive disorder , diabetic angiopathy , Diabetic Nephropathies , Drug-Related Side Effects and Adverse Reactions , echinococcosis , Ehlers-Danlos syndrome arthrochalasia type 1 , end stage renal disease , epilepsy , esophageal varix , Experimental Arthritis , Experimental Liver Cirrhosis , Experimental Sarcoma , extrahepatic cholestasis , Familial Dysalbuminemic Hyperthyroxinemia , familial hyperlipidemia , Fibrosis , gastric cardia adenocarcinoma , genetic disease , glomerulonephritis , Hantavirus hemorrhagic fever with renal syndrome , heart disease , hemolytic-uremic syndrome , Hepatic Insufficiency , hepatitis , hepatocellular carcinoma , Hepatomegaly , HIV Seropositivity , human immunodeficiency virus infectious disease , Hydrops Fetalis , hypertension , hyperthyroxinemia , Hypoalbuminemia , Hypoproteinemia , Hypotension , interstitial nephritis , Keloid , kidney disease , leukemia , liver cirrhosis , lung adenocarcinoma , Lung Injury , lung non-small cell carcinoma , membranoproliferative glomerulonephritis , membranous glomerulonephritis , middle cerebral artery infarction , multiple myeloma , muscular disease , Myocardial Reperfusion Injury , nephritis , nephrosis , nephrotic syndrome , obstructive jaundice , Occupational Diseases , Pain , pancreas disease , pancreatic cancer , pancreatic ductal carcinoma , Pancreatic Fistula , pancreatitis , Paroxysmal Atrial Fibrillation , Perennial Allergic Rhinitis , pneumonia , Poisoning , Postoperative Complications , pre-eclampsia , primary biliary cholangitis , protein-energy malnutrition , proteinuria , psoriasis , pulmonary emphysema , Reperfusion Injury , respiratory system disease , Reye syndrome , root caries , Sepsis , Serum Sickness , silicosis , Stevens-Johnson syndrome , Stomach Neoplasms , Stroke , suppurative otitis media , thrombocytopenia , twin-to-twin transfusion syndrome , ulcerative colitis , urticaria , uveitis , Zollinger-Ellison syndrome Cyp2b3 Acute Lymphoblastic Leukemia, with Lymphomatous Features , acute myeloid leukemia , autism spectrum disorder , Carpenter syndrome 2 , Chemical and Drug Induced Liver Injury , cholestasis , congenital hypoplastic anemia , craniosynostosis 1 , Diamond-Blackfan anemia , drug dependence , Drug Overdose , Efavirenz, Poor Metabolism of , end stage renal disease , Experimental Diabetes Mellitus , gliosarcoma , hepatocellular carcinoma , heroin dependence , human immunodeficiency virus infectious disease , maple syrup urine disease , Metabolic Side Effects of Drugs and Substances , neonatal abstinence syndrome , nicotine dependence , tuberculosis Pon1 abdominal aortic aneurysm , Acute Coronary Syndrome , acute lymphoblastic leukemia , Agricultural Workers' Diseases , Albuminuria , allergic rhinitis , Alzheimer's disease , amyotrophic lateral sclerosis , amyotrophic lateral sclerosis type 1 , anemia , arteriosclerosis , Arteritis , atherosclerosis , autistic disorder , Behcet's disease , beta thalassemia , beta-thalassemia major , Birth Weight , bone disease , Brain Neoplasms , breast cancer , capillary leak syndrome , cardiovascular system disease , cataract , celiac disease , cerebral cavernous malformation , cerebral infarction , Chemical and Drug Induced Liver Injury , cholestasis , chronic lymphocytic leukemia , chronic obstructive pulmonary disease , Colorectal Neoplasms , congestive heart failure , Constipation , coronary artery disease , coronary artery vasospasm , Coronary Disease , Crohn's disease , dementia , depressive disorder , Diabetes Complications , diabetes mellitus , diabetic angiopathy , Diabetic Nephropathies , diabetic retinopathy , disease of metabolism , exfoliation syndrome , Experimental Diabetes Mellitus , Genetic Predisposition to Disease , glucose intolerance , heart disease , Hematologic Neoplasms , hemorrhoid , hepatocellular carcinoma , Hypercholesterolemia , hyperglycemia , hyperhomocysteinemia , Hyperlipoproteinemia Type II , Hyperlipoproteinemias , hypertension , hyperthyroidism , Hypertriglyceridemia , IgA vasculitis , Insulin Resistance , iron deficiency anemia , keratoconus , Kuhnt-Junius degeneration , Lung Neoplasms , lymphoma , macular degeneration , male infertility , membranoproliferative glomerulonephritis , Metabolic Syndrome , Micronuclei, Chromosome-Defective , multiple myeloma , myocardial infarction , Nasal Polyps , non-Hodgkin lymphoma , Occupational Diseases , open-angle glaucoma , Organophosphate Poisoning , periodontal disease , persian gulf syndrome , pleomorphic xanthoastrocytoma , Prenatal Exposure Delayed Effects , primary open angle glaucoma , Primitive Neuroectodermal Tumors , prostate cancer , Prostatic Neoplasms , proteinuria , retinal vein occlusion , rheumatoid arthritis , secondary Parkinson disease , sickle cell anemia , Sjogren's syndrome , spina bifida , Spinal Cord Injuries , steatotic liver disease , toxic encephalopathy , type 1 diabetes mellitus , type 2 diabetes mellitus , ulcerative colitis , urinary bladder cancer , vitamin B12 deficiency , Yin Deficiency
abdominal aortic aneurysm Pon1 Acute Coronary Syndrome Alb , Pon1 acute kidney failure Alb Acute Liver Failure Alb Acute Lung Injury Alb acute lymphoblastic leukemia Pon1 Acute Lymphoblastic Leukemia, with Lymphomatous Features Cyp2b3 acute myeloid leukemia Cyp2b3 acute stress disorder Ache adult respiratory distress syndrome Alb Agricultural Workers' Diseases Pon1 Albuminuria Alb , Pon1 alcoholic hepatitis Alb allergic disease Alb allergic rhinitis Pon1 Alzheimer's disease Ache , Pon1 amphetamine abuse Ache amyloidosis Ache amyotrophic lateral sclerosis Pon1 amyotrophic lateral sclerosis type 1 Pon1 Analbuminemia Alb anemia Ache , Pon1 angioedema Alb Animal Disease Models Alb anuria Alb arteriosclerosis Pon1 Arteritis Pon1 aseptic meningitis Alb atherosclerosis Pon1 autism spectrum disorder Ache , Cyp2b3 autistic disorder Pon1 autoimmune thrombocytopenic purpura Alb azoospermia Alb bacterial meningitis Ache Behcet's disease Pon1 beta thalassemia Pon1 beta-thalassemia major Pon1 biliary tract benign neoplasm Alb Binge Drinking Ache Birth Weight Pon1 blood protein disease Alb bone disease Pon1 brain disease Alb Brain Injuries Alb brain ischemia Alb Brain Neoplasms Pon1 breast cancer Pon1 Breast Neoplasms Ache Burns Alb Cadmium Poisoning Ache cannabis dependence Ache capillary leak syndrome Pon1 Carcinoid Tumor Alb cardiovascular system disease Alb , Pon1 Carpenter syndrome 2 Cyp2b3 cataract Pon1 celiac disease Pon1 cerebral cavernous malformation Pon1 cerebral infarction Pon1 Chemical and Drug Induced Liver Injury Alb , Cyp2b3 , Pon1 Chemically-Induced Disorders Alb cholangiocarcinoma Alb cholestasis Alb , Cyp2b3 , Pon1 Chronic Allograft Nephropathy Alb chronic lymphocytic leukemia Pon1 chronic obstructive pulmonary disease Pon1 Colorectal Neoplasms Ache , Alb , Pon1 congenital hypoplastic anemia Cyp2b3 congestive heart failure Alb , Pon1 Constipation Pon1 coronary artery disease Pon1 coronary artery vasospasm Pon1 Coronary Disease Pon1 COVID-19 Alb craniosynostosis 1 Cyp2b3 Crohn's disease Pon1 Delayed Hypersensitivity Alb dementia Pon1 depressive disorder Alb , Pon1 Diabetes Complications Pon1 diabetes mellitus Pon1 diabetic angiopathy Alb , Pon1 Diabetic Nephropathies Alb , Pon1 diabetic retinopathy Pon1 Diamond-Blackfan anemia Cyp2b3 disease of metabolism Pon1 drug dependence Ache , Cyp2b3 Drug Overdose Cyp2b3 Drug-Related Side Effects and Adverse Reactions Ache , Alb echinococcosis Alb Efavirenz, Poor Metabolism of Cyp2b3 Ehlers-Danlos syndrome arthrochalasia type 1 Alb end stage renal disease Alb , Cyp2b3 Endotoxemia Ache epilepsy Ache , Alb esophageal varix Alb exfoliation syndrome Pon1 Experimental Arthritis Alb Experimental Diabetes Mellitus Ache , Cyp2b3 , Pon1 Experimental Liver Cirrhosis Ache , Alb Experimental Sarcoma Alb extrahepatic cholestasis Alb Familial Dysalbuminemic Hyperthyroxinemia Alb familial hyperlipidemia Alb Fibrosis Alb gastric cardia adenocarcinoma Alb genetic disease Alb Genetic Predisposition to Disease Pon1 gliosarcoma Cyp2b3 glomerulonephritis Alb glucose intolerance Pon1 Growth Disorders Ache Hantavirus hemorrhagic fever with renal syndrome Alb heart disease Alb , Pon1 Hematologic Neoplasms Pon1 hemolytic-uremic syndrome Alb hemorrhoid Pon1 Hepatic Insufficiency Alb hepatitis Alb hepatocellular carcinoma Alb , Cyp2b3 , Pon1 Hepatomegaly Alb heroin dependence Ache , Cyp2b3 Hirschsprung's disease Ache HIV Seropositivity Alb human immunodeficiency virus infectious disease Alb , Cyp2b3 Huntington's disease Ache Hydrops Fetalis Alb Hypercholesterolemia Pon1 hyperglycemia Pon1 hyperhomocysteinemia Pon1 Hyperlipoproteinemia Type II Pon1 Hyperlipoproteinemias Pon1 hypertension Alb , Pon1 hyperthyroidism Pon1 hyperthyroxinemia Alb Hypertriglyceridemia Pon1 Hypoalbuminemia Alb Hypoproteinemia Alb Hypotension Alb IgA vasculitis Pon1 Insulin Resistance Pon1 interstitial nephritis Alb iron deficiency anemia Pon1 Keloid Alb keratoconus Pon1 kidney disease Alb Kuhnt-Junius degeneration Pon1 learning disability Ache leptospirosis Ache leukemia Alb liver cirrhosis Alb lung adenocarcinoma Alb Lung Injury Alb Lung Neoplasms Pon1 lung non-small cell carcinoma Alb lymphoma Pon1 macular degeneration Pon1 male infertility Pon1 maple syrup urine disease Cyp2b3 membranoproliferative glomerulonephritis Alb , Pon1 membranous glomerulonephritis Alb Memory Disorders Ache Metabolic Side Effects of Drugs and Substances Cyp2b3 Metabolic Syndrome Pon1 Micronuclei, Chromosome-Defective Pon1 middle cerebral artery infarction Alb movement disease Ache multiple myeloma Alb , Pon1 multiple sclerosis Ache muscular disease Alb muscular dystrophy Ache myasthenia gravis Ache myocardial infarction Pon1 Myocardial Reperfusion Injury Alb Nasal Polyps Pon1 neonatal abstinence syndrome Cyp2b3 nephritis Alb nephrosis Alb nephrotic syndrome Alb nervous system disease Ache nicotine dependence Cyp2b3 non-Hodgkin lymphoma Pon1 obesity Ache obstructive jaundice Alb Occupational Diseases Alb , Pon1 open-angle glaucoma Pon1 Organophosphate Poisoning Ache , Pon1 Pain Alb pancreas disease Alb pancreatic cancer Alb pancreatic ductal carcinoma Alb Pancreatic Fistula Alb pancreatitis Alb Parkinson's disease Ache Paroxysmal Atrial Fibrillation Alb Perennial Allergic Rhinitis Alb periodontal disease Pon1 persian gulf syndrome Pon1 pleomorphic xanthoastrocytoma Ache , Pon1 pneumonia Alb Poisoning Ache , Alb Postoperative Complications Alb pre-eclampsia Alb Prenatal Exposure Delayed Effects Pon1 Prenatal Injuries Ache primary biliary cholangitis Alb primary open angle glaucoma Pon1 Primitive Neuroectodermal Tumors Pon1 prostate cancer Pon1 Prostatic Neoplasms Ache , Pon1 protein-energy malnutrition Alb proteinuria Alb , Pon1 psoriasis Alb pulmonary emphysema Alb renal cell carcinoma Ache Reperfusion Injury Alb respiratory system disease Alb retinal vein occlusion Pon1 Reye syndrome Alb rheumatoid arthritis Pon1 root caries Alb secondary Parkinson disease Pon1 Sepsis Alb Serum Sickness Alb sickle cell anemia Pon1 silicosis Alb Sjogren's syndrome Pon1 spina bifida Pon1 Spinal Cord Injuries Pon1 steatotic liver disease Pon1 Stevens-Johnson syndrome Alb Stomach Neoplasms Alb Stroke Ache , Alb subacute delirium Ache suppurative otitis media Alb thrombocytopenia Alb toxic encephalopathy Pon1 Tremor Ache tuberculosis Cyp2b3 twin-to-twin transfusion syndrome Alb type 1 diabetes mellitus Ache , Pon1 type 2 diabetes mellitus Pon1 ulcerative colitis Alb , Pon1 urinary bladder cancer Ache , Pon1 urticaria Alb uveitis Alb vitamin B12 deficiency Pon1 Yin Deficiency Pon1 Zollinger-Ellison syndrome Alb
Pathway Annotations Associated with Genes in the organophosphate response pathway
Ache acetylcholine metabolic pathway , acetylcholine signaling pathway via muscarinic acetylcholine receptor , acetylcholine signaling pathway via nicotinic acetylcholine receptor , glycerophospholipid metabolic pathway , organophosphate response pathway Alb forkhead class A signaling pathway , organophosphate response pathway Cyp2b3 acetylsalicylic acid pharmacodynamics pathway , antipyrine drug pathway , arachidonic acid metabolic pathway , carbamazepine pharmacokinetics pathway , celecoxib pharmacodynamics pathway , clopidogrel pharmacodynamics pathway , clopidogrel pharmacokinetics pathway , cyclophosphamide pharmacodynamics pathway , cyclophosphamide pharmacokinetics pathway , diclofenac pharmacodynamics pathway , diflunisal pharmacodynamics pathway , etodolac pharmacodynamics pathway , fenoprofen pharmacodynamics pathway , flurbiprofen pharmacodynamics pathway , ibuprofen pharmacodynamics pathway , ifosfamide pharmacodynamics pathway , ifosfamide pharmacokinetics pathway , indometacin pharmacodynamics pathway , indometacin pharmacodynamics pathway , ketoprofen pharmacodynamics pathway , ketorolac pharmacodynamics pathway , leukotriene C4 synthase deficiency pathway , lornoxicam pharmacodynamics pathway , magnesium salicylate pharmacodynamics pathway , mefenamic acid pharmacodynamics pathway , meloxicam pharmacodynamics pathway , methadone pharmacodynamics pathway , methadone pharmacokinetics pathway , nabumetone pharmacodynamics pathway , naproxen pharmacodynamics pathway , neviparine pharmacokinetics pathway , nicotine pharmacodynamics pathway , nicotine pharmacokinetics pathway , organophosphate response pathway , paracetamol drug pathway , phase I biotransformation pathway via cytochrome P450 , piroxicam pharmacodynamics pathway , retinol metabolic pathway , salicylic acid pharmacodynamics pathway , sodium salicylate pharmacodynamics pathway , sorafenib pharmacokinetics pathway , sulindac pharmacodynamics pathway , tamoxifen pharmacodynamics pathway , tamoxifen pharmacokinetics pathway , tenoxicam pharmacodynamics pathway , tiaprofenic acid pharmacodynamics pathway , tolmetin pharmacodynamics pathway , tramadol pharmacokinetics pathway , valdecoxib pharmacodynamics pathway , valproic acid pharmacokinetics pathway , vitamin A deficiency pathway Pon1 clopidogrel pharmacodynamics pathway , clopidogrel pharmacokinetics pathway , organophosphate response pathway
References Associated with the organophosphate response pathway:
Chowdhary S, etal., Clin Chim Acta. 2014 Apr 20;431C:66-76. doi: 10.1016/j.cca.2014.01.024. Epub 2014 Feb 7.
Flaskos J Toxicol Lett. 2012 Feb 25;209(1):86-93. doi: 10.1016/j.toxlet.2011.11.026. Epub 2011 Dec 3.
Jokanovic M Toxicol Lett. 2009 Jul 10;188(1):1-10. doi: 10.1016/j.toxlet.2009.03.017. Epub 2009 Mar 31.
Marsillach J, etal., Toxicology. 2013 May 10;307:46-54. doi: 10.1016/j.tox.2012.12.007. Epub 2012 Dec 20.
Dvir H, etal., Chem Biol Interact. 2010 Sep 6;187(1-3):10-22. doi: 10.1016/j.cbi.2010.01.042. Epub 2010 Feb 4.
Barelli A, etal., Minerva Anestesiol. 2011 Dec;77(12):1197-203. Epub 2011 Jul 29.
Maxwell DM, etal., Chem Biol Interact. 2013 Mar 25;203(1):72-6. doi: 10.1016/j.cbi.2012.08.024. Epub 2012 Sep 12.
Soukup O, etal., Arch Toxicol. 2013 Apr;87(4):711-9. doi: 10.1007/s00204-012-0977-1. Epub 2012 Nov 21.
Carletti E, etal., J Am Chem Soc. 2008 Nov 26;130(47):16011-20. doi: 10.1021/ja804941z.
Macharia M, etal., J Cardiovasc Med (Hagerstown). 2012 Jul;13(7):443-53. doi: 10.2459/JCM.0b013e328354e3ac.
Raushel FM Nature. 2011 Jan 20;469(7330):310-1. doi: 10.1038/469310a.
Bigley AN and Raushel FM, Biochim Biophys Acta. 2013 Jan;1834(1):443-53. doi: 10.1016/j.bbapap.2012.04.004. Epub 2012 Apr 26.
Androutsopoulos VP, etal., Toxicology. 2013 May 10;307:89-94. doi: 10.1016/j.tox.2012.09.011. Epub 2012 Oct 2.
Chen Y Neurotoxicology. 2012 Jun;33(3):391-400. doi: 10.1016/j.neuro.2012.03.011. Epub 2012 Apr 2.
Jokanovic M Toxicol Lett. 2009 Oct 28;190(2):107-15. doi: 10.1016/j.toxlet.2009.07.025. Epub 2009 Aug 3.
Weissman BA and Raveh L, Toxicology. 2011 Dec 18;290(2-3):149-55. doi: 10.1016/j.tox.2011.09.004. Epub 2011 Sep 28.
Ontology Path Diagram:
Import into Pathway Studio: